Antibiotics - the Perfect Storm davidshlaes.substack.com

Chasing Resistance

substackcdn.com·2w·Substack

Treatment of Clostridioides difficile Infection

davidshlaes.substack.com·9w·Substack

C diff Infection in Children

davidshlaes.substack.com·17w·Substack

Ruminating on Antimicrobial Stewardship

academic.oup.com

·27w·Substack

Incentives for AMR Research

davidshlaes.substack.com·29w·Substack

Solutions for Antibiotic Needs

davidshlaes.substack.com·91w·Substack

Antibiotics

davidshlaes.substack.com·93w·Substack

Market strategies for sickle cell disease therapy vs. antibiotics

davidshlaes.substack.com·94w·Substack

Tackling C. diff

davidshlaes.substack.com·101w·Substack

First-of-its-kind License Agreement Forges Path to Expand Antibiotic Access in Low- and Middle-Income Countries

wipo.int·149w·Substack

A New Weapon Against Superbugs

businesswire.com·154w·Substack

Let's all Shed a Tear for the Pharmaceutical Industry

davidshlaes.substack.com·155w·Substack

Paratek and Destiny

davidshlaes.substack.com·155w·Substack

Pull Incentive for Antibiotic R&D from Europe

davidshlaes.substack.com·157w·Substack

Entasis Scores. Now What?

davidshlaes.substack.com·162w·Substack

Antibiotics - the Perfect Storm

davidshlaes.substack.com·167w·Substack

Antibiotic Biotech Execs Share Their Concerns

davidshlaes.substack.com·167w·Substack

The Fate of Another Antibiotic Biotech

davidshlaes.substack.com·176w·Substack

The Grinch Stole PASTEUR

davidshlaes.substack.com·179w·Substack

PASTEUR, Do or . . .

davidshlaes.substack.com·190w·Substack

Log in to enable infinite scrolling